Đang chuẩn bị liên kết để tải về tài liệu:
Restoration of angiogenic capacity of diabetes-insulted mesenchymal stem cells by oxytocin

Angiogenesis is the main therapeutic mechanism of cell therapy for cardiovascular diseases, but diabetes is reported to reduce the function and number of progenitor cells. Therefore, we studied the effect of streptozotocin-induced diabetes on the bone marrow-mesenchymal stem cell (MSC) function, and examined whether diabetes-impaired MSC could be rescued by pretreatment with oxytocin. |